1. Home
  2. SYNX vs XXII Comparison

SYNX vs XXII Comparison

Compare SYNX & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silynxcom Ltd.

SYNX

Silynxcom Ltd.

HOLD

Current Price

$1.17

Market Cap

6.5M

Sector

N/A

ML Signal

HOLD

Logo 22nd Century Group Inc.

XXII

22nd Century Group Inc.

HOLD

Current Price

$0.90

Market Cap

6.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SYNX
XXII
Founded
2005
1998
Country
Israel
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
6.1M
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
SYNX
XXII
Price
$1.17
$0.90
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
209.8K
180.9K
Earning Date
02-23-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,003,000.00
$20,346,000.00
Revenue This Year
$32.35
N/A
Revenue Next Year
N/A
$79.56
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.98
52 Week Low
$0.73
$0.75
52 Week High
$4.69
$287.27

Technical Indicators

Market Signals
Indicator
SYNX
XXII
Relative Strength Index (RSI) 56.35 46.08
Support Level $1.10 $0.86
Resistance Level $1.29 $0.99
Average True Range (ATR) 0.11 0.07
MACD 0.05 0.01
Stochastic Oscillator 83.98 62.60

Price Performance

Historical Comparison
SYNX
XXII

About SYNX Silynxcom Ltd.

Silynxcom Ltd is engaged in developing, manufacturing, marketing, and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat proved. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, markets, and sell push-to-talk devices, communication controllers, and communication device cables and connectors.

About XXII 22nd Century Group Inc.

22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.

Share on Social Networks: